Proscia, Ibex Medical Analytics Strike Prostate Cancer Diagnosis Partnership

By Author Proscia | March 11, 2021

Digital pathology firm Proscia and Ibex Medical Analytics have agreed to combine their respective technologies into an integrated product for artificial intelligence-based prostate cancer diagnosis.

The companies will join Proscia’s Concentriq image and data management platform with Ibex’s Galen Prostate system, which uses AI to help pathologists detect and grade prostate cancer in biopsies.

Our website uses cookies. By using this site, you agree to its use of cookies.